Abstract
Recently completed multi-national trials have demonstrated major patient benefits from neoadjuvant therapy from colon cancer. It is now timely to institute these treatment pathways in our MDTs for the benefit of our patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
